WVU010924: A Phase I Trial of Calaspargase Pegol-mknl in Combination with High Dose Cytarabine and Idarubicin in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

Title
A Phase I Trial of Calaspargase Pegol-mknl in Combination with High Dose Cytarabine and Idarubicin in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia
Principal Investigator
Emadi, Ashkan
Phase
I
Age Group
Adult
Applicable Disease Sites
Multiple Myeloma
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Abby Swiger, RN
Research Nurse
Phone: +1 304-293-1683
Email:

View on ClinicalTrials.gov